News | December 17, 2023
Dr. Reddy's becomes first Indian pharma company to debut on the DJSI
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Leading USA based genetic testing brand officially enters the Indian market
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Demonstrate significant bleed reduction in hemophilia A and B
New facility is part of Aptar Pharma’s global expansion program
There has been no loss or injury to human life
Subscribe To Our Newsletter & Stay Updated
